First Time Loading...

IO Biotech Inc
NASDAQ:IOBT

Watchlist Manager
IO Biotech Inc Logo
IO Biotech Inc
NASDAQ:IOBT
Watchlist
Price: 1.5899 USD 6.7%
Updated: May 7, 2024

IO Biotech Inc
Operating Income

Last Value
3-Years 3-Y CAGR
5-Years 5-Y CAGR
10-Years 10-Y CAGR
Quarterly
Annual
TTM
|

IO Biotech Inc
Operating Income Peer Comparison

Comparables:
GMAB
ZEAL
ASND
B
BAVA
BIOPOR

Competitive Operating Income Analysis
Latest Figures & CAGR of Competitors

Company Operating Income CAGR 3Y CAGR 5Y CAGR 10Y
IO Biotech Inc
NASDAQ:IOBT
Operating Income
-$91.4m
CAGR 3-Years
-108%
CAGR 5-Years
N/A
CAGR 10-Years
N/A
Genmab A/S
CSE:GMAB
Operating Income
kr5.3B
CAGR 3-Years
-6%
CAGR 5-Years
31%
CAGR 10-Years
54%
Zealand Pharma A/S
CSE:ZEAL
Operating Income
-kr561.2m
CAGR 3-Years
2%
CAGR 5-Years
-4%
CAGR 10-Years
-12%
Ascendis Pharma A/S
NASDAQ:ASND
Operating Income
-€361m
CAGR 3-Years
2%
CAGR 5-Years
-15%
CAGR 10-Years
N/A
B
Bavarian Nordic A/S
CSE:BAVA
Operating Income
kr2.1B
CAGR 3-Years
75%
CAGR 5-Years
N/A
CAGR 10-Years
51%
Bioporto A/S
CSE:BIOPOR
Operating Income
-kr60.2m
CAGR 3-Years
2%
CAGR 5-Years
-8%
CAGR 10-Years
-12%

See Also

What is IO Biotech Inc's Operating Income?
Operating Income
-91.4m USD

Based on the financial report for Dec 31, 2023, IO Biotech Inc's Operating Income amounts to -91.4m USD.

What is IO Biotech Inc's Operating Income growth rate?
Operating Income CAGR 3Y
-108%

Over the last year, the Operating Income growth was -28%. The average annual Operating Income growth rates for IO Biotech Inc have been -108% over the past three years .